Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 85

1.

Partial dysfunction of STAT1 profoundly reduces host resistance to flaviviral infection.

Larena M, Lobigs M.

Virology. 2017 Jun;506:1-6. doi: 10.1016/j.virol.2017.03.001. Epub 2017 Mar 7.

2.

Ectromelia virus N1L is essential for virulence but not dissemination in a classical model of mousepox.

Melo-Silva CR, Tscharke DC, Lobigs M, Koskinen A, Müllbacher A, Regner M.

Virus Res. 2017 Jan 15;228:61-65. doi: 10.1016/j.virusres.2016.11.017. Epub 2016 Nov 16.

PMID:
27865865
3.

Proteolytic cleavage analysis at the Murray Valley encephalitis virus NS1-2A junction.

Addis SN, Lee E, Bettadapura J, Lobigs M.

Virol J. 2015 Sep 17;12:144. doi: 10.1186/s12985-015-0375-4.

4.

Mutagenesis analysis of T380R mutation in the envelope protein of yellow fever virus.

Huang YJ, Nuckols JT, Horne KM, Vanlandingham D, Lobigs M, Higgs S.

Virol J. 2014 Mar 29;11:60. doi: 10.1186/1743-422X-11-60.

5.

Internal ribosome entry site-based attenuation of a flavivirus candidate vaccine and evaluation of the effect of beta interferon coexpression on vaccine properties.

Frese M, Lee E, Larena M, Lim PS, Rao S, Matthaei KI, Khromykh A, Ramshaw I, Lobigs M.

J Virol. 2014 Feb;88(4):2056-70. doi: 10.1128/JVI.03051-13. Epub 2013 Dec 4.

6.
7.

Cytolytic effector pathways and IFN-γ help protect against Japanese encephalitis.

Larena M, Regner M, Lobigs M.

Eur J Immunol. 2013 Jul;43(7):1789-98. doi: 10.1002/eji.201243152. Epub 2013 Jun 18.

8.

JE-ADVAX vaccine protection against Japanese encephalitis virus mediated by memory B cells in the absence of CD8(+) T cells and pre-exposure neutralizing antibody.

Larena M, Prow NA, Hall RA, Petrovsky N, Lobigs M.

J Virol. 2013 Apr;87(8):4395-402. doi: 10.1128/JVI.03144-12. Epub 2013 Feb 6.

9.

The chemokine receptor CCR5, a therapeutic target for HIV/AIDS antagonists, is critical for recovery in a mouse model of Japanese encephalitis.

Larena M, Regner M, Lobigs M.

PLoS One. 2012;7(9):e44834. doi: 10.1371/journal.pone.0044834. Epub 2012 Sep 21.

10.

Identification of residues in West Nile virus pre-membrane protein that influence viral particle secretion and virulence.

Setoh YX, Prow NA, Hobson-Peters J, Lobigs M, Young PR, Khromykh AA, Hall RA.

J Gen Virol. 2012 Sep;93(Pt 9):1965-75. doi: 10.1099/vir.0.044453-0. Epub 2012 Jul 4.

PMID:
22764317
11.

Feasibility of cross-protective vaccination against flaviviruses of the Japanese encephalitis serocomplex.

Lobigs M, Diamond MS.

Expert Rev Vaccines. 2012 Feb;11(2):177-87. doi: 10.1586/erv.11.180. Review.

12.

The ectromelia virus SPI-2 protein causes lethal mousepox by preventing NK cell responses.

Melo-Silva CR, Tscharke DC, Lobigs M, Koskinen A, Wong YC, Buller RM, Müllbacher A, Regner M.

J Virol. 2011 Nov;85(21):11170-82. doi: 10.1128/JVI.00256-11. Epub 2011 Aug 17.

13.

Determinants of attenuation in the envelope protein of the flavivirus Alfuy.

Prow NA, May FJ, Westlake DJ, Hurrelbrink RJ, Biron RM, Leung JY, McMinn PC, Clark DC, Mackenzie JS, Lobigs M, Khromykh AA, Hall RA.

J Gen Virol. 2011 Oct;92(Pt 10):2286-96. doi: 10.1099/vir.0.034793-0. Epub 2011 Jul 6.

PMID:
21733886
14.

Pivotal role of antibody and subsidiary contribution of CD8+ T cells to recovery from infection in a murine model of Japanese encephalitis.

Larena M, Regner M, Lee E, Lobigs M.

J Virol. 2011 Jun;85(11):5446-55. doi: 10.1128/JVI.02611-10. Epub 2011 Mar 30.

15.

Both E protein glycans adversely affect dengue virus infectivity but are beneficial for virion release.

Lee E, Leang SK, Davidson A, Lobigs M.

J Virol. 2010 May;84(10):5171-80. doi: 10.1128/JVI.01900-09. Epub 2010 Mar 10.

16.

A flavivirus signal peptide balances the catalytic activity of two proteases and thereby facilitates virus morphogenesis.

Lobigs M, Lee E, Ng ML, Pavy M, Lobigs P.

Virology. 2010 May 25;401(1):80-9. doi: 10.1016/j.virol.2010.02.008. Epub 2010 Mar 6.

17.

Cytotoxic T cells are the predominant players providing cross-protective immunity induced by {gamma}-irradiated influenza A viruses.

Furuya Y, Chan J, Regner M, Lobigs M, Koskinen A, Kok T, Manavis J, Li P, Müllbacher A, Alsharifi M.

J Virol. 2010 May;84(9):4212-21. doi: 10.1128/JVI.02508-09. Epub 2010 Feb 17.

18.

Effect of inactivation method on the cross-protective immunity induced by whole 'killed' influenza A viruses and commercial vaccine preparations.

Furuya Y, Regner M, Lobigs M, Koskinen A, Müllbacher A, Alsharifi M.

J Gen Virol. 2010 Jun;91(Pt 6):1450-60. doi: 10.1099/vir.0.018168-0. Epub 2010 Feb 10.

PMID:
20147516
19.

An inactivated Vero cell-grown Japanese encephalitis vaccine formulated with Advax, a novel inulin-based adjuvant, induces protective neutralizing antibody against homologous and heterologous flaviviruses.

Lobigs M, Pavy M, Hall RA, Lobigs P, Cooper P, Komiya T, Toriniwa H, Petrovsky N.

J Gen Virol. 2010 Jun;91(Pt 6):1407-17. doi: 10.1099/vir.0.019190-0. Epub 2010 Feb 3.

20.

Caspase-dependent inhibition of mousepox replication by gzmB.

Pardo J, Gálvez EM, Koskinen A, Simon MM, Lobigs M, Regner M, Müllbacher A.

PLoS One. 2009 Oct 19;4(10):e7512. doi: 10.1371/journal.pone.0007512.

21.

Intranasal flu vaccine protective against seasonal and H5N1 avian influenza infections.

Alsharifi M, Furuya Y, Bowden TR, Lobigs M, Koskinen A, Regner M, Trinidad L, Boyle DB, Müllbacher A.

PLoS One. 2009;4(4):e5336. doi: 10.1371/journal.pone.0005336. Epub 2009 Apr 29.

22.

Live chimeric and inactivated Japanese encephalitis virus vaccines differ in their cross-protective values against Murray Valley encephalitis virus.

Lobigs M, Larena M, Alsharifi M, Lee E, Pavy M.

J Virol. 2009 Mar;83(6):2436-45. doi: 10.1128/JVI.02273-08. Epub 2008 Dec 24.

23.

Restricted Semliki Forest virus replication in perforin and Fas-ligand double-deficient mice.

Alsharifi M, Lobigs M, Bettadapura J, Koskinen A, Müllbacher A.

J Gen Virol. 2008 Aug;89(Pt 8):1942-4. doi: 10.1099/vir.0.83626-0.

PMID:
18632965
24.
25.

In situ reactions of monoclonal antibodies with a viable mutant of Murray Valley encephalitis virus reveal an absence of dimeric NS1 protein.

Clark DC, Lobigs M, Lee E, Howard MJ, Clark K, Blitvich BJ, Hall RA.

J Gen Virol. 2007 Apr;88(Pt 4):1175-83.

PMID:
17374761
26.

CD8(+) T cell-mediated immune responses in West Nile virus (Sarafend strain) encephalitis are independent of gamma interferon.

Wang Y, Lobigs M, Lee E, Koskinen A, Müllbacher A.

J Gen Virol. 2006 Dec;87(Pt 12):3599-609.

PMID:
17098975
27.
28.

Exhaustion of type I interferon response following an acute viral infection.

Alsharifi M, Regner M, Blanden R, Lobigs M, Lee E, Koskinen A, Müllbacher A.

J Immunol. 2006 Sep 1;177(5):3235-41.

29.

The mitochondrial protein Bak is pivotal for gliotoxin-induced apoptosis and a critical host factor of Aspergillus fumigatus virulence in mice.

Pardo J, Urban C, Galvez EM, Ekert PG, Müller U, Kwon-Chung J, Lobigs M, Müllbacher A, Wallich R, Borner C, Simon MM.

J Cell Biol. 2006 Aug 14;174(4):509-19. Epub 2006 Aug 7.

30.

Cytotoxic T-cell immunity as a target for influenza vaccines.

Müllbacher A, Lobigs M, Alsharifi M, Regner M.

Lancet Infect Dis. 2006 May;6(5):255-6. No abstract available.

PMID:
16631540
31.

NK cell-mediated immunopathology during an acute viral infection of the CNS.

Alsharifi M, Lobigs M, Simon MM, Kersten A, Müller K, Koskinen A, Lee E, Müllbacher A.

Eur J Immunol. 2006 Apr;36(4):887-96.

33.

Biological, antigenic and phylogenetic characterization of the flavivirus Alfuy.

May FJ, Lobigs M, Lee E, Gendle DJ, Mackenzie JS, Broom AK, Conlan JV, Hall RA.

J Gen Virol. 2006 Feb;87(Pt 2):329-37.

PMID:
16432019
34.

Physical and functional interactions of the cytomegalovirus US6 glycoprotein with the transporter associated with antigen processing.

Halenius A, Momburg F, Reinhard H, Bauer D, Lobigs M, Hengel H.

J Biol Chem. 2006 Mar 3;281(9):5383-90. Epub 2005 Dec 15.

35.

Antiviral effect of the heparan sulfate mimetic, PI-88, against dengue and encephalitic flaviviruses.

Lee E, Pavy M, Young N, Freeman C, Lobigs M.

Antiviral Res. 2006 Jan;69(1):31-8. Epub 2005 Nov 10.

PMID:
16309754
36.

Type I interferons trigger systemic, partial lymphocyte activation in response to viral infection.

Alsharifi M, Lobigs M, Regner M, Lee E, Koskinen A, Müllbacher A.

J Immunol. 2005 Oct 1;175(7):4635-40.

37.

Can we really learn from model pathogens?

Müllbacher A, Regner M, Wang Y, Lee E, Lobigs M, Simon M.

Trends Immunol. 2004 Oct;25(10):524-8. Review.

PMID:
15364054
39.

Evidence that a mechanism for efficient flavivirus budding upregulates MHC class I.

Lobigs M, Müllbacher A, Lee E.

Immunol Cell Biol. 2004 Apr;82(2):184-8.

PMID:
15061772
40.

Exocytosis and Fas mediated cytolytic mechanisms exert protection from West Nile virus induced encephalitis in mice.

Wang Y, Lobigs M, Lee E, Müllbacher A.

Immunol Cell Biol. 2004 Apr;82(2):170-3.

PMID:
15061770
41.

Immunobiology of mosquito-borne encephalitic flaviviruses.

Müllbacher A, Lobigs M, Lee E.

Adv Virus Res. 2003;60:87-120. No abstract available.

PMID:
14689692
43.

CD8+ T cells mediate recovery and immunopathology in West Nile virus encephalitis.

Wang Y, Lobigs M, Lee E, Müllbacher A.

J Virol. 2003 Dec;77(24):13323-34.

44.

MHC class I up-regulation by flaviviruses: Immune interaction with unknown advantage to host or pathogen.

Lobigs M, Müllbacher A, Regner M.

Immunol Cell Biol. 2003 Jun;81(3):217-23. Review.

PMID:
12752686
46.

Role of type I and type II interferon responses in recovery from infection with an encephalitic flavivirus.

Lobigs M, Müllbacher A, Wang Y, Pavy M, Lee E.

J Gen Virol. 2003 Mar;84(Pt 3):567-72.

PMID:
12604807
47.
49.

Lack of both Fas ligand and perforin protects from flavivirus-mediated encephalitis in mice.

Licon Luna RM, Lee E, Müllbacher A, Blanden RV, Langman R, Lobigs M.

J Virol. 2002 Apr;76(7):3202-11.

50.

Effector cytolotic function but not IFN-gamma production in cytotoxic T cells triggered by virus-infected target cells in vitro.

Regner M, Lobigs M, Blanden RV, Müllbacher A.

Scand J Immunol. 2001 Oct;54(4):366-74. Erratum in: Scand J Immunol 2001 Dec;54(6):640-1.

Supplemental Content

Loading ...
Support Center